Background Patients with advanced-stage, low-tumour-burden follicular lymphoma have conventionally undergone watchful waiting until disease progression. We assessed whether rituximab use could delay the need for chemotherapy or radiotherapy compared with watchful waiting and the effect of this strategy on quality of life (QoL)
BACKGROUND: Patients with follicular lymphoma can have long survival times, but disease progression ...
The German study groups, the German Low-Grade Lymphoma Study Group (GLSG) and Ostdeutsche Studiengru...
Purpose Rituximab (Rit) therapy added to involved-field radiation therapy (RT) has been proposed as ...
PURPOSEPatients with follicular lymphoma (FL) registered in the F2-study and initially managed witho...
none14siPURPOSE: Patients with follicular lymphoma (FL) registered in the F2-study and initially ma...
Given the incurable yet indolent nature of follicular lymphoma (FL) and the lack of a survival benef...
The incidence of follicular lymphoma, a low-grade malignant B-cell lymphoma, is increasing in most A...
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular lymphoma (FL),...
The potential benefits of extended rituximab treatment have been investigated in a randomized trial ...
BACKGROUND. It is unclear whether new treatment modalities have improved the survival of follicular ...
Background: Less than 20% of patients with follicular lymphoma (FL) present with Ann Arbor Stage I o...
BACKGROUND: It is unclear whether new treatment modalities have improved the survival of follicular ...
Patients with follicular lymphoma can have long survival times, but disease progression typically oc...
Background: Less than 20 % of patients with follicular lymphoma (FL) present with Ann Arbor Stage I ...
Abstract Standard of care for patients with symptomatic, advanced‐stage follicular lymphoma (FL) is ...
BACKGROUND: Patients with follicular lymphoma can have long survival times, but disease progression ...
The German study groups, the German Low-Grade Lymphoma Study Group (GLSG) and Ostdeutsche Studiengru...
Purpose Rituximab (Rit) therapy added to involved-field radiation therapy (RT) has been proposed as ...
PURPOSEPatients with follicular lymphoma (FL) registered in the F2-study and initially managed witho...
none14siPURPOSE: Patients with follicular lymphoma (FL) registered in the F2-study and initially ma...
Given the incurable yet indolent nature of follicular lymphoma (FL) and the lack of a survival benef...
The incidence of follicular lymphoma, a low-grade malignant B-cell lymphoma, is increasing in most A...
Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular lymphoma (FL),...
The potential benefits of extended rituximab treatment have been investigated in a randomized trial ...
BACKGROUND. It is unclear whether new treatment modalities have improved the survival of follicular ...
Background: Less than 20% of patients with follicular lymphoma (FL) present with Ann Arbor Stage I o...
BACKGROUND: It is unclear whether new treatment modalities have improved the survival of follicular ...
Patients with follicular lymphoma can have long survival times, but disease progression typically oc...
Background: Less than 20 % of patients with follicular lymphoma (FL) present with Ann Arbor Stage I ...
Abstract Standard of care for patients with symptomatic, advanced‐stage follicular lymphoma (FL) is ...
BACKGROUND: Patients with follicular lymphoma can have long survival times, but disease progression ...
The German study groups, the German Low-Grade Lymphoma Study Group (GLSG) and Ostdeutsche Studiengru...
Purpose Rituximab (Rit) therapy added to involved-field radiation therapy (RT) has been proposed as ...